VIVA BIOTECH (01873) spent HKD 121,000 on January 16 to repurchase 150,000 shares.

date
16/01/2025
avatar
GMT Eight
VIVA BIOTECH (01873) announced that on January 16, 2025, it spent HK$121,000 to repurchase 150,000 shares.
pre
Northbound funds | Northbound trading net buying of 6.298 billion, chip stocks show differentiation. Innovent Bio (01801) suffered nearly 200 million Hong Kong dollars in domestic sales.
Huiyu Pharmaceutical's (688553.SH) subsidiary, the injection of Tilkolaning, has obtained listing approval in Ireland.
next

RECOMMEND

recommend

Yihe Jie's application for an IPO on the Shenzhen Stock Exchange has been "terminated (withdrawn)". Please note the risk of slower-than-expected promotion in the fuel cell vehicle market.

date
22 min ago
recommend

Song Xuetao: What incremental signals were released at the press conference of the five ministries?

date
38 min ago
recommend

Morgan Stanley: Key points for visiting the Chinese humanoid Siasun Robot & Automation industry

date
51 min ago

©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.

Contact: contact@gmteight.com